Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antivirus medical broth of compound Neilupaer

An antiviral and compound technology, applied in antiviral agents, pharmaceutical formulations, plant raw materials, etc., can solve problems such as poor treatment effect, and achieve the effects of convenient preparation process, stable product quality, and help in antibody generation.

Active Publication Date: 2006-02-01
HETIAN UYGHUR PHARMA
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

If prevention is not carried out in time, the treatment effect is poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Example 1, the compound Nerupar antiviral decoction contains 100 parts of water lily, 100 parts of chicory, 100 parts of eucalyptus, 80 parts of hollyhock flower, 80 parts of divine herb, 80 parts of Artemisia annua, 48 parts of grapes, 2% ethylparaben of conventional medicinal dosage, 10% benzoic acid of conventional medicinal dosage, 16 parts of protein sugar.

Embodiment 2

[0012] Example 2, the compound Nerupar antiviral decoction contains 180 parts of water lily, 180 parts of chicory, 180 parts of eucalyptus, 120 parts of hollyhock, 120 parts of divine herb, 120 parts of wormwood, 72 parts of grapes, 2% ethylparaben of conventional medicinal dosage, 10% benzoic acid of conventional medicinal dosage, 24 parts of protein sugar.

Embodiment 3

[0013] Example 3, the compound Nerupar antiviral decoction contains 100 parts of water lily, 180 parts of chicory, 100 parts of eucalyptus, 120 parts of hollyhock, 80 parts of divine herb, 120 parts of wormwood, 120 parts of Artemisia annua, and 48 parts of grapes, 2% ethylparaben of conventional medicinal dosage, 10% benzoic acid of conventional medicinal dosage, 24 parts of protein sugar.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Maximum tolerated doseaaaaaaaaaa
Login to View More

Abstract

An antiviral decoction for improving immunity and preventing SARS is prepared from nipagin ethylester, benzoic acid, proteose, and 7 Chinese-medicinal materials including water lily flower, chicory herb, dwarf flowering cherry seed, etc.

Description

technical field [0001] The invention relates to a pharmaceutical composition and a production method thereof, which is a compound Nerupal antiviral decoction and a preparation process thereof, and is especially suitable for preventing atypical pneumonia. Background technique [0002] SARS is a highly contagious respiratory disease caused by a coronavirus that seriously threatens human physical and mental health. The World Health Organization calls this contagious atypical pneumonia severe acute respiratory syndrome (Severe Acuute Respiratory Syndromes), referred to as SARS. [0003] Chinese Uyghur medicine is an important part of Chinese medicine. The Chinese Uyghur people have formed a complete theoretical system of Uyghur medicine in their long-term life practice. Atypical pneumonia is listed as one of the epidemics in Uyghur medicine, and it belongs to the category of "Waba" disease (that is, plague), and it has been recognized that this type of disease is highly contagi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/87A61K36/62A61K36/28A61K36/73A61P31/12
Inventor 顾政一孙玉华邢建国许馨燕阿不都热依木阿合旦郭风元
Owner HETIAN UYGHUR PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com